Trial intelligence / Profile preview

MIROIR: Biomarkers to Predict Mucosal Healing in Ulcerative Colitis

NCT07653750Terminated

Sponsor
Centre Hospitalier Universitaire de Clermont-Ferrand
Start
Jun 2021
Primary completion
Jun 2026
Countries
1
01

Overview

Single-arm trial, sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Primary endpoints: Serum measurements: CHI3L1 and NGAL-MMP9 at 12 months and Fecal measurements: CHI3L1, MMP9 at 12 months. Started Jun 2021; status: terminated.

Beyond the preview

Go deeper on NCT07653750.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07653750.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call